Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
Submitted by Anonymous (not verified) on 25 July 2025 - 11:00
Ixchiq: temporary restriction on vaccinating people 65 years and older to be lifted
Orphan designation: Elesclomol-copper Treatment of Menkes disease, 22/06/2025 Positive
Submitted by Anonymous (not verified) on 25 July 2025 - 10:52
Orphan designation: Elesclomol-copper Treatment of Menkes disease, 22/06/2025 Positive
Orphan designation: zanidatamab Treatment of biliary tract cancer, 27/06/2025 Positive
Submitted by Anonymous (not verified) on 25 July 2025 - 10:45
Orphan designation: zanidatamab Treatment of biliary tract cancer, 27/06/2025 Positive
Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 18, Status: Authorised
Submitted by Anonymous (not verified) on 25 July 2025 - 10:43
Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 25 July 2025 - 9:45
Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 25 July 2025 - 9:37
Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 25 July 2025 - 9:26
Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 21, Status: Authorised
Submitted by Anonymous (not verified) on 24 July 2025 - 17:00
Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 21, Status: Authorised
Innovation Task Force (ITF) briefing meeting report
Submitted by Anonymous (not verified) on 24 July 2025 - 16:02
Innovation Task Force (ITF) briefing meeting report
Innovation Task Force (ITF) briefing meeting request form
Submitted by Anonymous (not verified) on 24 July 2025 - 15:58
Innovation Task Force (ITF) briefing meeting request form